NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial... NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. 더 보기
Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm PR Newswire NEW YORK, Sept. 23, 2024 NEW YORK, Sept. 23, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...
Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals PR Newswire BLUE BELL, Pa., Sept. 20, 2024 This Acquisition Enhances PRN Physician...
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a definitive asset purchase agreement (the “Agreement”) with PRN Physician...
Eyecare product revenue increased 8% driven by higher sales of Avenova®-branded products through online channels Sales and marketing expenses declined 13% reflecting efficient growth through...
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova®-branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1102 | -14.885857085 | 0.7403 | 0.75 | 0.621 | 86082 | 0.67428673 | CS |
4 | 0.1303 | 26.0704281713 | 0.4998 | 1.0099 | 0.47031 | 7685228 | 0.73856527 | CS |
12 | -1.3599 | -68.3366834171 | 1.99 | 2.2599 | 0.3611 | 2856100 | 0.72964316 | CS |
26 | -2.6599 | -80.8480243161 | 3.29 | 9.079 | 0.3611 | 5511430 | 3.78228789 | CS |
52 | -13.0339 | -95.3886124122 | 13.664 | 14.346465 | 0.3611 | 3742251 | 4.26062665 | CS |
156 | -697.6199 | -99.9097601146 | 698.25 | 771.75 | 0.3611 | 1723368 | 64.9430171 | CS |
260 | -735.5949 | -99.9144147509 | 736.225 | 2670.5 | 0.3611 | 2110322 | 672.61307235 | CS |
기호 | 가격 | 볼륨 |
---|---|---|
YANGDirexion Daily FTSE China Bear 3X Shares New | US$ 3.187 (-1.64%) | 93.9M |
FXIiShares China Large Cap | US$ 33.45 (0.69%) | 69.11M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 38.67 (2.22%) | 58.43M |
XLFFinancial Select Sector | US$ 46.51 (1.93%) | 51.9M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 18.96 (-2.27%) | 47.86M |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관